Atlas Trials

Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells

Clinical trial NCT00078520 · COMPLETED

Trial details

NCT number
NCT00078520
Sponsor
Baylor College of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LeukemiaLeukemia, B-Cell, Chronic
Start date
2003-01-01
Primary completion
2010-03-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.